Commentary

Now viewing page 1 of 70

8/31/2023 | Commentary
Ninepoint Alternative Health Fund August 2023 Commentary
The month of August was very positive for the Ninepoint Alternative Health Fund as the healthcare sector witnessed strong data to support...
8/31/2023 | Commentary
Ninepoint Fixed Income Strategy August 2023 Commentary
As expected, the BoC paused once again at its September meeting, keeping the overnight rate at 5%. While inflation still remains too...
8/31/2023 | Commentary
Ninepoint Focused Global Dividend Fund August 2023 Commentary
Year-to-date to August 31, the Ninepoint Focused Global Dividend Fund generated a total return of 9.84% compared to the S&P Global...
8/31/2023 | Commentary
Ninepoint Global Infrastructure Fund August 2023 Commentary
Year-to-date to August 31, the Ninepoint Global Infrastructure Fund generated a total return of 1.25% compared to the MSCI World Core...
8/31/2023 | Commentary
Ninepoint Global Real Estate Fund August 2023 Commentary
Year-to-date to August 31, the Ninepoint Global Real Estate Fund generated a total return of 0.63% compared to the MSCI World IMI Core...
7/31/2023 | Commentary
Ninepoint Focused Global Dividend Fund July 2023 Commentary
Year-to-date to July 31, the Ninepoint Focused Global Dividend Fund generated a total return of 8.30% compared to the S&P Global 1200...
7/31/2023 | Commentary
Ninepoint Global Infrastructure Fund July 2023 Commentary
Year-to-date to July 31, the Ninepoint Global Infrastructure Fund generated a total return of 0.81% compared to the MSCI World Core...
7/31/2023 | Commentary
Ninepoint Global Real Estate Fund July 2023 Commentary
Year-to-date to July 31, the Ninepoint Global Real Estate Fund generated a total return of 1.70% compared to the MSCI World IMI Core...
7/31/2023 | Commentary
Ninepoint Fixed Income Strategy July 2023 Commentary
As widely anticipated, the BoC and Fed both hiked interest rates at their July meetings. Messaging about future actions is becoming...
7/31/2023 | Commentary
Ninepoint Alternative Health Fund July 2023 Commentary
In this month’s commentary we analyse Terrascend’s (TSND) recent up-listing to the TSX and the implications of up-listing on other...

Now viewing page 1 of 70

Funds

Categories

Keywords